OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 5,424 results

Filters: chemo-immunotherapy

The role of combination chemo-immunotherapy in advanced non-small cell lung cancer.
Danilo Rocco, Luigi Della Gravara, Ciro Battiloro, Cesare Gridelli
Expert Rev Anticancer Ther. 07, 2019.19(7):561-568 Print-Electronic
Source:PubMed
PMID: 31188040 doi:10.1080/14737140.2019.1631800
Dual fluorescence imaging-guided programmed delivery of doxorubicin and CpG nanoparticles to modulate tumor microenvironment for effective chemo-immunotherapy.
Xia Dong, Afeng Yang, Yun Bai, Deling Kong, Feng Lv
Biomaterials. 02, 2020.230:119659 Print-Electronic
Source:PubMed
PMID: 31831223 doi:10.1016/j.biomaterials.2019.119659
Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer.
Yue Wang, Dhamotharan Pattarayan, Haozhe Huang, Yueshan Zhao, Sihan Li, Yifei Wang, Min Zhang, Song Li, Da Yang
Res Sq. Sep 14, 2023.: Electronic
Source:PubMed
PMID: 37790509 doi:10.21203/rs.3.rs-3290264/v1
Chemotherapy or chemo-immunotherapy as first-line treatment for extensive-stage small-cell lung cancer: a meta-analysis.
Ching-Yi Chen, Wang-Chun Chen, Chao-Ming Hung, Yu-Feng Wei
Immunotherapy. 10, 2021.13(14):1165-1177 Print-Electronic
Source:PubMed
PMID: 34261336 doi:10.2217/imt-2021-0135
Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
O A Brinkmann, F Bruns, F J Prott, L Hertle
Anticancer Res. 1999 Mar-Apr.19(2C):1583-7 Print
Source:PubMed
PMID: 10365150 doi:
Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.
A H Paterson, A M Edwards, M Nutting, D Schinnour, L Takats, A McClelland
Cancer Clin Trials. 1980.3(1):5-10 Print
Source:PubMed
PMID: 6993035 doi:
Chemotherapy plus single/double immunotherapy in the treatment of non-oncogene addicted advanced non-small cell lung cancer: where do we stand and where are we going?
Danilo Rocco, Luigi Della Gravara, Nicola Franzese, Paolo Maione, Cesare Gridelli
Expert Rev Anticancer Ther. Feb, 2022.22(2):183-189 Print-Electronic
Source:PubMed
PMID: 34989305 doi:10.1080/14737140.2022.2026772
[Initial experiences with a nation-wide Austrian study of adjuvant chemo- and immunotherapy of colorectal cancer following radical surgery].
K Karrer, H Denck, N Pridun
Acta Med Austriaca Suppl. 1979.6:325-6 Print
Source:PubMed
PMID: 299221 doi:
Mitophagy: a new actor in the efficacy of chemo-immunotherapy.
Emeric Limagne, François Ghiringhelli
Autophagy. 12, 2022.18(12):3033-3034 Print-Electronic
Source:PubMed
PMID: 35532360 doi:10.1080/15548627.2022.2069439
The MOEO algorithm for multi-objective optimization of the cancer immuno-chemotherapy.
K Nozad, S M Varedi-Koulaei, M Nazari
Comput Biol Med. Nov, 2024.182:109094 Print-Electronic
Source:PubMed
PMID: 39241325 doi:10.1016/j.compbiomed.2024.109094
0